Lodo, Genentech partner on R&D for microbial-derived therapies

Lodo Therapeutics Corp. (New York, N.Y.) and the Genentech Inc. unit of Roche (SIX:ROG; OTCQB:RHHBY) partnered to discover compounds with Lodo's Metagenomics

Read the full 220 word article

User Sign In